Is there a role for vitamin C in preventing osteoporosis and fractures? A review of the potential underlying mechanisms and current epidemiological evidence

Nutrition Research Reviews

Volumn 27, Issue 2, 2014, Pages 268-283

  Finck, Henriette ^a   Hart, Andrew R ^a   Jennings, Amy ^a   Welch, Ailsa A ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Ascorbic acid; Bone mineral density; Collagen; Fracture risk; Vitamin C

Indexed keywords

ASCORBIC ACID; COLLAGEN;

BONE DENSITY; BONE DEVELOPMENT; BONE MATRIX; COLLAGEN SYNTHESIS; CONSENSUS; DIETARY INTAKE; FRACTURE; FRUIT; HUMAN; NONHUMAN; NUTRITIONAL STATUS; OSTEOBLASTOGENESIS; OSTEOCLASTOGENESIS; OSTEOPOROSIS; REVIEW; RISK REDUCTION; VEGETABLE; VITAMIN SUPPLEMENTATION; ANIMAL; BONE; DIET; DIET THERAPY; DRUG EFFECTS; EPIDEMIOLOGY; FRACTURES, BONE; METABOLISM;

ANIMALIA;

ANIMALS; ASCORBIC ACID; BONE AND BONES; DIET; EPIDEMIOLOGIC METHODS; FRACTURES, BONE; HUMANS; NUTRITIONAL STATUS; OSTEOPOROSIS;

EID: 84921904726     PISSN: 09544224     EISSN: 14752700     Source Type: Journal    
DOI: 10.1017/S0954422414000195     Document Type: Review

References (91)

1. Anonymous (1993) Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94, 646-650.
2. European Foundation for Osteoporosis and National Osteoporosis Foundation (1997) Who are candidates for prevention and treatment for osteoporosis. Osteoporos Int 7, 1-6.
3. Johnell O & Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17, 1726-1733.
4. Kanis JA, Borgstrom F, De Laet C, et al. (2005) Assessment of fracture risk. Osteoporos Int 16, 581-589.
5. United Nations (2013) World Population Prospects: The 2012 Revision, Highlights and Advance Tables. ESA/P/WP.228. New York: United Nations.
6. New SA, Bolton-Smith C, Grubb DA, et al. (1997) Nutritional influences on bone mineral density: a cross-sectional study in premenopausal women. Am J Clin Nutr 65, 1831-1839.
7. Tucker KL, Hannan MT, Chen H, et al. (1999) Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr 69, 727-736.
8. New SA, Robins SP, Campbell MK, et al. (2000) Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health? Am J Clin Nutr 71, 142-151.
9. Prynne CJ, Mishra GD, O'Connell MA, et al. (2006) Fruit and vegetable intakes and bone mineral status: a cross sectional study in 5 age and sex cohorts. Am J Clin Nutr 83, 1420-1428.
10. Lanham-New SA (2008) The balance of bone health: tipping the scales in favor of potassium-rich, bicarbonate-rich foods. J Nutr 138, 172S-177S.
11. Hall SL & Greendale GA (1998) The relation of dietary vitamin C intake to bone mineral density: results from the PEPI study. Calcif Tissue Int 63, 183-189.
12. Simon JA & Hudes ES (2001) Relation of ascorbic acid to bone mineral density and self-reported fractures among US adults. Am J Epidemiol 154, 427-433.
13. Department of Health (1991) Dietary Reference Values for Food Energy and Nutrients for the United Kingdom: Report of the Panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy. London: HMSO.
14. Royal Society of Chemistry (2002) McCance and Widdow-son's the Composition of Foods, 6th summary ed., [Food Standards Agency and Institute of Food Research, editor]. Cambridge: Royal Society of Chemistry.
15. Togari A, Arai M, Nakagawa S, et al. (1995) Alteration of bone status with ascorbic acid deficiency in ODS (osteogenic disorder Shionogi) rats. Jpn J Pharmacol 68, 255-261.
16. Sakamoto Y & Takano Y (2002) Morphological influence of ascorbic acid deficiency on endochondral ossification in osteogenic disorder Shionogi rat. Anat Rec 268, 93-104.
17. Hasegawa T, Li M, Hara K, et al. (2011) Morphological assessment of bone mineralization in tibial metaphyses of ascorbic acid-deficient ODS rats. Biomed Res 32, 259-269.
18. Nojiri H, Saita Y, Morikawa D, et al. (2011) Cytoplasmic superoxide causes bone fragility owing to low-turnover osteoporosis and impaired collagen cross-linking. J Bone Miner Res 26, 2682-2694.
19. Hill AB (1965) The environment and disease: association or causation? Proc R Soc Med 58, 295-300.
20. Robertson WV (1961) The biochemical role of ascorbic acid in connective tissue. Ann N Y Acad Sci 92, 159-167.
21. Pradel W, Mai R, Gedrange T, et al. (2008) Cell passage and composition of culture medium effects proliferation and differentiation of human osteoblast-like cells from facial bone. J Physiol Pharmacol 59, Suppl. 5, 47-58.
22. Hie M & Tsukamoto I (2011) Vitamin C-deficiency stimulates osteoclastogenesis with an increase in RANK expression. J Nutr Biochem 22, 164-171.
23. Park JK, Lee EM, Kim AY, et al. (2012) Vitamin C deficiency accelerates bone loss inducing an increase in PPAR-g expression in SMP30 knockout mice. Int J Exp Pathol 93, 332-340.
24. Urban K, Hohling HJ, Luttenberg B, et al. (2012) An in vitro study of osteoblast vitality influenced by the vitamins C and E. Head Face Med 8, 25.
25. Le Nihouannen D, Barralet JE, Fong JE, et al. (2010) Ascorbic acid accelerates osteoclast formation and death. Bone 46, 1336-1343.
26. Ragab AA, Lavish SA, Banks MA, et al. (1998) Osteoclast differentiation requires ascorbic acid. J Bone Miner Res 13, 970-977.
27. Otsuka E, Kato Y, Hirose S, et al. (2000) Role of ascorbic acid in the osteoclast formation: induction of osteoclast differentiation factor with formation of the extracellular collagen matrix. Endocrinology 141, 3006-3011.
28. Takarada T, Hinoi E, Kambe Y, et al. (2007) Osteoblast protects osteoclast devoid of sodium-dependent vitamin C transporters from oxidative cytotoxicity of ascorbic acid. Eur J Pharmacol 575, 1-11.
29. Tsuneto M, Yamazaki H, Yoshino M, et al. (2005) Ascorbic acid promotes osteoclastogenesis from embryonic stem cells. Biochem Biophys Res Commun 335, 1239-1246.
30. Xiao XH, Liao EY, Zhou HD, et al. (2005) Ascorbic acid inhibits osteoclastogenesis of RAW264.7 cells induced by receptor activated nuclear factor kB ligand (RANKL) in vitro. J Endocrinol Invest 28, 253-260.
31. Harada S, Matsumoto T & Ogata E (1991) Role of ascorbic acid in the regulation of proliferation in osteoblast-like MC3T3-E1 cells. J Bone Miner Res 6, 903-908.
32. Otsuka E, Yamaguchi A, Hirose S, et al. (1999) Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid. Am J Physiol Cell Physiol 277, C132-C138.
33. Siggelkow H, Rebenstorff K, Kurre W, et al. (1999) Development of the osteoblast phenotype in primary human osteo-blasts in culture: comparison with rat calvarial cells in osteoblast differentiation. J Cell Biochem 75, 22-35.
34. Carinci F, Pezzetti F, Spina AM, et al. (2005) Effect of Vitamin C on pre-osteoblast gene expression. Arch Oral Biol 50, 481-496.
35. Ali AA, Weinstein RS, Stewart SA, et al. (2005) Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology 146, 1226-1235.
36. Liu ZP, Li WX, Yu B, et al. (2005) Effects of trans-resveratrol from Polygonum cuspidatum on bone loss using the ovari-ectomized rat model. J Med Food 8, 14-19.
37. Geesin JC, Darr D, Kaufman R, et al. (1988) Ascorbic acid specifically increases type I and type III procollagen messenger RNA levels in human skin fibroblast. J Invest Dermatol 90, 420-424.
38. 3 and ascorbic acid in bone-derived cells. J Bone Miner Res 5, 1157-1167.
39. Chan D, Lamande SR, Cole WG, et al. (1990) Regulation of procollagen synthesis and processing during ascorbate-induced extracellular matrix accumulation in vitro. Biochem J 269, 175-181.
40. Franceschi RT & Iyer BS (1992) Relationship between collagen synthesis and expression of the osteoblast pheno-type in MC3T3-E1 cells. J Bone Miner Res 7, 235-246.
41. Hutton JJ, Tappel AL & Udenfriend S (1967) Cofactor and substrate requirements of collagen proline hydroxylase. Arch Biochem Biophys 118, 231-240.
42. Barnes MJ (1975) Function of ascorbic acid in collagen metabolism. Ann N Y Acad Sci 258, 264-277.
43. Kivirikko KI & Myllyla R (1982) Posttranslational enzymes in the biosynthesis of collagen: intracellular enzymes. Methods Enzymol 82, 245-304.
44. Myllyla R, Majamaa K, Gunzler V, et al. (1984) Ascorbate is consumed stoichiometrically in the uncoupled reactions catalyzed by prolyl 4-hydroxylase and lysyl hydroxylase. J Biol Chem 259, 5403-5405.
45. Stone N & Meister A (1962) Function of ascorbic acid in the conversion of proline to collagen hydroxyproline. Nature 194, 555-557.
46. Gottlieb AA, Kaplan A & Udenfriend S (1966) Further evidence for the accumulation of a hydroxyproline-deficient, collagenase-degradable protein during collagen biosynthesis in vitro. J Biol Chem 241, 1551-1555.
47. Manning JM & Meister A (1966) Conversion of proline to collagen hydroxyproline. Biochemistry 5, 1154-1165.
48. Bates CJ, Prynne CJ & Levene CI (1972) The synthesis of underhydroxylated collagen by 3 T6 mouse fibroblasts in culture. Biochim Biophys Acta 263, 397-405.
49. Peterkofsky B (1972) The effect of ascorbic acid on collagen polypeptide synthesis and proline hydroxylation during the growth of cultured fibroblasts. Arch Biochem Biophys 152, 318-328.
50. Franceschi RT, Iyer BS & Cui Y (1994) Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res 9, 843-854.
51. Harwood R, Grant ME & Jackson DS (1974) Collagen biosynthesis. Characterization of subcellular fractions from embyonic chick fibroblasts and the intracellular localization of protocollagen prolyl and protocollagen lysyl hydroxy-lases. Biochem J 144, 123-130.
52. Uitto J & Prockop DJ (1974) Hydroxylation of peptide-bound proline and lysine before and after chain completion of the polypeptide chains of procollagen. Arch Biochem Biophys 164, 210-217.
53. Nabavi N, Pustylnik S & Harrison RE (2012) Rab GTPase mediated procollagen trafficking in ascorbic acid stimulated osteoblasts. PLOS ONE 7, e46265.
54. Dehghan M, Akhtar-Danesh N, McMillan CR, et al. (2007) Is plasma vitamin C an appropriate biomarker of vitamin C intake? A systematic review and meta-analysis. Nutr J 6, 41.
55. Bates B, Lennox A, Bates C, et al (2011) National Diet and Nutrition Survey: Headline Results from Years 1 and 2 (Combined) of the Rolling Programme 2008/2009-2009/10. London: Food Standards Agency.
56. Food and Nutrition Board and Institute of Medicine (2000) Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids: A Report of the Panel on Dietary Antioxidants and Related Compounds, Subcommitties on Upper Reference Levels of Nutrients and of Interpretation and Use of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Washington, DC: National Academies Press.
57. Hoffer A (1971) Ascorbic acid and toxicity. N Engl J Med 285, 635-636.
58. Taylor EN, Stampfer MJ & Curhan GC (2004) Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol 15, 3225-3232.
59. Levine M, Rumsey SC, Daruwala R, et al. (1999) Criteria and recommendations for vitamin C intake. JAMA 281, 1415-1423.
60. Drewnowski A, Rock CL, Henderson SA, et al. (1997) Serum b-carotene and vitamin C as biomarkers of vegetable and fruit intakes in a community-based sample of French adults. Am J Clin Nutr 65, 1796-1802.
61. Galan P, Viteri FE, Bertrais S, et al. (2005) Serum concentrations of b-carotene, vitamins C and E, zinc and selenium are influenced by sex, age, diet, smoking status, alcohol consumption and corpulence in a general French adult population. Eur J Clin Nutr 59, 1181-1190.
62. Faure H, Preziosi P, Roussel AM, et al. (2006) Factors influencing blood concentration of retinol, a-tocopherol, vitamin C, and b-carotene in the French participants of the SU.VI.MAX trial. Eur J Clin Nutr 60, 706-717.
63. Canoy D, Wareham N, Welch A, et al. (2005) Plasma ascorbic acid concentrations and fat distribution in 19068 British men and women in the European Prospective Investigation into Cancer and Nutrition Norfolk cohort study. Am J Clin Nutr 82, 1203-1209.
64. Chow CK, Thacker RR, Changchit C, et al. (1986) Lower levels of vitamin C and carotenes in plasma of cigarette smokers. J Am Coll Nutr 5, 305-312.
65. Schectman G, Byrd JC & Gruchow HW (1989) The influence of smoking on vitamin C status in adults. Am J Public Health 79, 158-162.
66. Scrimshaw NS & SanGiovanni JP (1997) Synergism of nutrition, infection, and immunity: an overview. Am J Clin Nutr 66, 464S-477S.
67. Levine M, Conry-Cantilena C, Wang Y, et al. (1996) Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci USA 93, 3704-3709.
68. Levine M, Wang Y, Padayatty SJ, et al. (2001) A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci USA 98, 9842-9846.
69. Bates B, Lennox A, Prentice A, et al (2012) National Diet and Nutrition Survey: Headline Results from Years 1, 2 and 3 (combined) of the Rolling Programme 2008/2009-2010/11. London: Food Standards Agency.
70. Ruiz-Ramos M, Vargas LA, Van der Goes TIF, et al. (2010) Supplementation of ascorbic acid and a-tocopherol is useful to preventing bone loss linked to oxidative stress in elderly. J Nutr Health Aging 14, 467-472.
71. Maimoun L, Simar D, Caillaud C, et al. (2008) Effect of antioxidants and exercise on bone metabolism. J Sports Sci 26, 251-258.
72. Chuin A, Labonte M, Tessier D, et al. (2009) Effect of anti-oxidants combined to resistance training on BMD in elderly women: a pilot study. Osteoporos Int 20, 1253-1258.
73. Kaptoge S, Welch A, McTaggart A, et al. (2003) Effects of dietary nutrients and food groups on bone loss from the proximal femur in men and women in the 7th and 8th decades of age. Osteoporos Int 14, 418-428.
74. Sahni S, Hannan MT, Gagnon D, et al. (2008) High vitamin C intake is associated with lower 4-year bone loss in elderly men. J Nutr 138, 1931-1938.
75. Holbrook TL, Barrett-Connor E, Klauber M, et al. (1991) A population-based comparison of quantitative dual-energy X-ray absorptiometry with dual-photon absorptiometry of the spine and hip. Calcif Tissue Int 49, 305-307.
76. Sahni S, Hannan MT, Gagnon D, et al. (2009) Protective effect of total and supplemental vitamin C intake on the risk of hip fracture-a 17-year follow-up from the Framing-ham Osteoporosis Study. Osteoporos Int 20, 1853-1861.
77. Falch JA, Mowe M & Bohmer T (1998) Low levels of serum ascorbic acid in elderly patients with hip fracture. Scand J Clin Lab Invest 58, 225-228.
78. Maggio D, Barabani M, Pierandrei M, et al. (2003) Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 88, 1523-1527.
79. 12, folate and the risk of osteoporotic fractures. A case-control study. Int J Vitam Nutr Res 77, 359-368.
80. Lumbers M, New SA, Gibson S, et al. (2001) Nutritional status in elderly female hip fracture patients: comparison with an age-matched home living group attending day centres. Br J Nutr 85, 733-740.
81. Park HM, Heo J & Park Y (2011) Calcium from plant sources is beneficial to lowering the risk of osteoporosis in postme-nopausal Korean women. Nutr Res 31, 27-32.
82. Morton DJ, Barrett-Connor E & Schneider DL (2001) Vitamin C supplement use and bone mineral density in postmeno-pausal women. J Bone Miner Res 16, 135-140.
83. Sowers MR, Wallace RB & Lemke JH (1985) Correlates of mid-radius bone density among postmenopausal women: a community study. Am J Clin Nutr 41, 1045-1053.
84. Wolf RL, Cauley JA, Pettinger M, et al. (2005) Lack of a relation between vitamin and mineral antioxidants and bone mineral density: results from the Women's Health Initiative. Am J Clin Nutr 82, 581-588.
85. Pasco JA, Henry MJ, Wilkinson LK, et al. (2006) Antioxidant vitamin supplements and markers of bone turnover in a community sample of nonsmoking women. J Womens Health (Larchmt) 15, 295-300.
86. Leveille SG, LaCroix AZ, Koepsell TD, et al. (1997) Dietary vitamin C and bone mineral density in postmenopausal women in Washington State, USA. J Epidemiol Community Health 51, 479-485.
87. Sugiura M, Nakamura M, Ogawa K, et al. (2011) Dietary patterns of antioxidant vitamin and carotenoid intake associated with bone mineral density: findings from post-menopausal Japanese female subjects. Osteoporos Int 22, 143-152.
88. Ilich JZ, Brownbill RA & Tamborini L (2003) Bone and nutrition in elderly women: protein, energy, and calcium as main determinants of bone mineral density. Eur J Clin Nutr 57, 554-565.
89. Bates CJ, Thurnham SI, Bingham SA, et al (1997) Biochemical markers of nutrient intake. In Design Concepts in Nutritional Epidemiology, 2nd ed., pp. 170-240 [BM Margetts and M Nelson, editors]. Oxford: Oxford University Press.
90. Podmore ID, Griffiths HR, Herbert KE, et al. (1998) Vitamin C exhibits pro-oxidant properties. Nature 392, 559.
91. Takamizawa S, Maehata Y, Imai K, et al. (2004) Effects of ascorbic acid and ascorbic acid 2-phosphate, a long-acting vitamin C derivative, on the proliferation and differentiation of human osteoblast-like cells. Cell Biol Int 28, 255-265.